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REPORT
Association of the Asporin D14 Allele
with Lumbar-Disc Degeneration in Asians
You-Qiang Song,1,3,11 Kenneth M.C. Cheung,2,11 Daniel W.H. Ho,1 Sandy C.S. Poon,1 Kazuhiro Chiba,4
Yoshiharu Kawaguchi,4,5 Yuichiro Hirose,10 Mauro Alini,6 Sibylle Grad,6 Anita F.Y. Yee,2
John C.Y. Leong,7 Keith D.K. Luk,2 Shea-Ping Yip,8 Jaro Karppinen,9 Kathryn S.E. Cheah,1
Pak Sham,3 Shiro Ikegawa,10 and Danny Chan1,*
Lumbar-disc degeneration (LDD) is a polygenic disease. Susceptibility genes reported so far are mainly extracellular matrix proteins. D14
allele of asporin (ASPN) is associated with osteoarthritis (OA). Candidate-gene association studies showed that the D14 allele is also
signiﬁcantly associated with LDD in Chinese and Japanese individuals. Meta-analysis showed that individuals harboring a D14 allele
had higher risk with a summary odds ratio of 1.70 (p ¼ 0.000013). ASPN expression in vertebral discs increased with age and degener-
ation. Our results indicate ASPN is a LDD gene in Asians, and common risk factors may be considered for OA and LDD.Lumbar-disc degeneration (LDD) is a major cause of low
back pain. Approximately 80% of the global population
experience low back pain in their life time, presenting
a huge medical and economical burden to society.1 There
is a signiﬁcant genetic contribution in LDD. Twin studies
demonstrated 74% heritability on the basis of magnetic
resonance imaging (MRI) of the spine.2–4 Also, genetic
association studies have identiﬁed a number of risk factors
(see recent review).5 The majority of these risk factors for
LDD result from changes in sequences of genes encoding
extracellular matrix (ECM) proteins expressed in the
nucleus pulposus (inner structure) and annulus ﬁbrosus
(outer layer) of the disc, such as type IX collagen
(COL9A2 and COL9A3),6–8 aggrecan (AGC1),9 and cartilage
intermediate layer protein (CILP).10 These ﬁndings lead us
to the hypothesis that LDD is caused by changes in the
structural integrity of the intervertebral disc.
Recently, an extracellularmatrix protein, asporin (ASPN),
was shown to be associated with osteoarthritis (OA) of the
knee.11–13 ASPN belongs to the small leucine-rich proteo-
glycan (SLRP) family. It contains a unique aspartate (D) res-
idues repeat in the N terminus, which is a polymorphic
region in the gene with alleles that contains D repeats rang-
ing from 9–20 residues.14 The D14 polymorphism with 14
D residues is the risk allele identiﬁed for OA.11 Functional
studies demonstrated that ASPN inhibited in vitro chon-
drogenesis and expression of Col2a1 and Agc1 through
inhibition of TGF-b signaling, with a stronger inhibitory ef-
fect for asporin D14 over others.11 Given that OA and LDD
are both degenerative diseases of skeletal joint regions, and
that many of the genes expressed in cartilage are also ex-
pressed in the intervertebral disc, we hypothesize that ASPN
is an excellent candidate as a susceptibility gene to LDD.We tested for association of ASPN with LDD in two large
Asian cohorts of Chinese and Japanese ethnicities. The
Chinese cohort consisted of 1055 individuals recruited
from the general population. LDD status was assessed by
MRI, with severity of LDD graded with the Schneiderman’s
classiﬁcation.15 Because age is a factor in LDD, we used
a sliding-window method for an adjustment.16 In brief,
the method normalizes the LDD score by (1) logarithmic
transformation of the quantitative variable to reduce skew-
ness, (2) deﬁnition of an age band for each individual as
the age of the individual plus or minus 5 years, and (3)
standardization of each individual’s quantitative variable
value by ﬁrst subtracting the mean trait value and then di-
viding by the standard deviation of the trait, in the individ-
ual’s age band. This normalization of LDD scores allows us
to divide the cohort into two groups; individuals with nor-
malized scores above and below the median were classiﬁed
as cases (527) and controls (528), respectively. Differences
in allele or genotype frequencies between groups were
assessed by odds ratios and chi-square tests. The Japanese
cohort is an extension of one previously published for an
association with CILP.10 The cohort consisted of 608 con-
trols and 745 cases. All LDD cases had a history of sciatica
for longer than 3 months, and LDD conﬁrmed with MRI
graded with the Schneiderman’s classiﬁcation.15 Disc her-
niation was present in all cases.
We analyzed the ASPN D-repeat polymorphisms. Similar
to previous ﬁndings for the association study in OA,11 the
most common allele is D13, and there were no signiﬁcant
differences between the case (LDD) and control groups in
both cohorts (Table 1). However, the D14 allele was over-
represented in the case groups (Table 1). The D14 allele is
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Table 1. Distribution of the D Repeat Alleles of ASPN in Chinese and Japanese Cohorts
Cohort
Allele
D9 D10 D11 D12 D13 D14 D15 D16 D17 D18 D19 D20 Total
Chinese
Case Count 1 0 4 213 652 98 36 38 9 3 0 0 1054
Case % 0.1 0 0.4 20.2 61.9 9.3 3.4 3.6 0.9 0.3 0 0 100
Control Count 0 1 4 236 666 68 30 37 10 3 0 1 1056
Control % 0 0.1 0.4 22.3 63.1 6.4 2.8 3.5 0.9 0.3 0 0.1 100
Japanese
Case Count 0 0 1 230 888 116 50 137 64 2 2 0 1490
Case % 0 0 0.1 15.4 59.6 7.8 3.4 9.2 4.3 0.1 0.1 0 100
Control Count 0 0 1 167 793 58 56 88 51 1 1 0 1216
Control % 0 0 0.1 13.7 65.2 4.8 4.6 7.2 4.2 0.1 0.1 0 100
Statistical analyses for the D14 allele: Chinese cohort (OR ¼ 1.49, 95%CI ¼ 1.08-2.06, p ¼ 0.015), Japanese cohort (OR ¼ 1.69, 95% CI ¼ 1.22-2.33,
p ¼ 0.0015), and meta-analysis (OR ¼ 1.58, 95% CI ¼ 1.26-1.99, p ¼ 0.000081).Chinese and Japanese cohorts, respectively (Table 1). With
the D14 genotype in a dominant model, individuals carry-
ing at least one D14 allele are at risk with an odds ratio of
1.66 and 1.79 for the Chinese and Japanese cohorts, re-
spectively (Table 2).
To integrate the results of the two populations, we
performed a meta-analysis (random-effect model) by using
the software ‘‘MIX.’’17 This program uses Excel as a calcula-
tion and programming platform and has been validated
against two major software packages, STATA and Compre-
hensive Meta-Analysis Version 2. This meta-analysis
showed a summary odds ratio of 1.58 (95% CI ¼ 1.26–
1.99, p ¼ 0.00081) (Table 1) for the allele frequency, and
an overall odds ratio of 1.70 (95% CI ¼ 1.35–2.20, p ¼
0.000013) (Table 2) for the D14 genotype in a dominant
model, strongly supporting the D14 allele of ASPN as
a risk factor for LDD. In the Chinese cohort, we also found
a correlation of the D14 allele with the number of degener-
ated discs in an individual (Table 3).
To assess ASPN in the pathogenesis of LDD, we investi-
gated its expression in the intervertebral discs by using mi-
croarray analysis of genes expressed in cells isolated from
the nucleus pulposus and annulus ﬁbrosus, from ‘‘normal’’
individuals of various ages with no evidence of disc degen-
eration. The expression of ASPN, normalized to the average
expression in 2- and 22-year-old samples, was similar
and slightly above average. However, it was upregulated
3- to 5-fold in 46-year-old nucleus pulposus and annulus
ﬁbrosus cells, with a corresponding downregulation of
COL2A1 and AGC1 expression with age (Figure 1A). Real-time RT-PCR also showed an upregulated ASPN expression
in degenerative discs (Figure 1B). Although the sample size
is small to make deﬁnitive conclusions, there is a trend for
a reduced expression of COL2A1 and AGC1 in degenerate
samples, with decreased COL2A1 expression in annulus
ﬁbrosus and decreased AGC1 expression in nucleus pulpo-
sus and end-plate tissues (Figure 1B).
ASPN expression was further evaluated by in situ hy-
bridization, comparing ‘‘normal’’ nondegenerative (16–35
years) and degenerative (20–49 years) discs obtained from
surgery. ASPN mRNA was clearly detectable in cells from
degenerative disc samples, but only traces appeared in nor-
mal samples (Figure 1C). Immunostaining with an anti-
body speciﬁc for ASPN also showed a stronger staining
for all degenerative discs analyzed compared to ‘‘normal’’
nondegenerative tissues (Figure 1D). In ‘‘normal’’ nonde-
generative intervertebral discs, TGF-b1 can be detected in
the cartilage end plate, nucleus pulposus, and annulus ﬁ-
brosus (Figure 1E), in regions where ASPN is also localized.
Interestingly, there is a trend for a lower staining intensity
in LDD disc samples when compared with ‘‘normal’’ non-
degenerative samples (Figure 1E).
Given that previous in vitro studies have demonstrated
ASPN can exert a negative effect on TGF-b signaling
through direct interaction,11,18 and that we have shown
ASPN is upregulated with age and degeneration, it is rea-
sonable to suggest that an inhibitory effect on cell func-
tion would occur if ASPN is overexpressed in intervertebral
disc tissues, and individuals with the D14 allele could
be compromised further and would become moreTable 2. Association between the Presence of the ASPN D14 Allele and LDD
Cohort Case D14þ/D14 (%D14þ) Control D14þ/D14 (%D14þ) p Value OR (95% CI)
Chinese 94/433 (17.8) 61/467 (11.6) 0.0039 1.66 (1.17-2.35)
Japanese 112/633 (15.0) 55/553 (9.0) 0.00087 1.78 (1.26-2.51)
Meta-Analysis 0.000013 1.70 (1.35-2.20)
‘‘D14þ’’ refers to subjects harboring one or two D14 alleles. ‘‘D14’’ refers to subjects harboring no D14 alleles.
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susceptible to LDD. The signiﬁcance of ASPN in the regu-
lation of TGF-b signaling for intervertebral disc function is
not clear, but our data together with previous ﬁnding for
an association of CILP10 to LDD suggest that factors that
alter TGF-b signaling may contribute to the pathogenesis
of LDD.
Of particular relevance is the phenotype deﬁnition for
LDD in the two cohorts, in which the deﬁnition in the
Chinese cohort is independent of symptoms relating to
pain, whereas the Japanese cohort is dependent on painful
disc herniations. This suggests that the ASPN association is
relevant across a broader spectrum of the disease. In the
Chinese cohort, there is a trend for an association between
ASPN and severity of LDD. A smaller p value for an associ-
ation of the D14 allele in the Japanese cohort, in which the
phenotype deﬁnition correlated with severe LDD, sup-
ported this observation. The signiﬁcance of ASPN in LDD
in non-Asian populations awaits replication studies of
additional large cohorts.
The ﬁnding that the same alleles predispose to cartilage
degeneration indifferent cartilage types isofparticular inter-
est, suggesting the presence of common pathomechanisms
for degenerative ‘‘cartilage diseases.’’ Similar scenario may
be applicable to other susceptibility genes of OA and LDD.
Thus, systematic comparative association analyses of sus-
ceptibility genes for OA, LDD, and other degenerative
Table 3. Correlation of the Number of Degenerative Lumbar
Discs and ASPN D14 Allele in the Chinese Cohort
Individuals (%)
Number of Degenerated Lumbar Disc D14þ D14
0 21 (14) 205 (23)
1 45 (29) 278 (31)
2 43 (28) 230 (26)
3 26 (17) 113 (13)
4 11 (7) 54 (6)
5 9 (6) 20 (2)
‘‘D14þ’’ refers to subjects harboring one or two D14 alleles. ‘‘D14’’ refers to
subjects harboring no D14 alleles; p ¼ 0.0010.
Figure 1. Expression of ASPN, COL2A1,
AGC1, and TGF-b1 in Normal and LDD
Discs
(A) Relative expression levels of ASPN,
COL2A1, and AGC1 in disc cells from micro-
array analysis with the CODELINK plate-
form.
(B) Dot plots of real-time RT-PCR analysis
of ASPN, COL2A1, and AGC1 expression in
normal (n ¼ 4, age 16–39) and LDD tissues
(n ¼ 4, age 21–49). The bar represents the
average value in each group. A p value is
given for a statistical difference between
normal and LDD groups, and n.s. denotes
nonsignificance.
(C) ASPN in situ hybridization.
(D and E) Immunostaining of (D) ASPN and
(E) TGF-b1, in ‘‘normal’’ nondegenerative
(35-year-old) and LDD (40-year-old) disc
tissues. The following abbreviations are
used: AF, annulus fibrosus; NP, nucleus pul-
posus; and EP, end plate.
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cartilage diseases will be informative, with the possibility of
developing common therapeutic and preventative treat-
ments.
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